Advanced search
Publication Cover
Expert Review of Vaccines Volume 23, 2024 - Issue 1
Submit an article Journal homepage
1,651
Views
0
CrossRef citations to date
0
Altmetric
Review

Neoadjuvant personalized cancer vaccines: the final frontier?

Guilhem Richarda EpiVax Therapeutics, Inc., Providence, RI, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-6544-4257View further author information
ORCID Icon,
Nicole Ruggieroa EpiVax Therapeutics, Inc., Providence, RI, USAView further author information
,
Gary D. Steinberga EpiVax Therapeutics, Inc., Providence, RI, USA;b RUSH University, Chicago, IL, USAORCID Iconhttps://orcid.org/0000-0003-4469-0624View further author information
ORCID Icon,
William D. Martinc EpiVax, Inc., Providence, RI, USAORCID Iconhttps://orcid.org/0000-0001-8694-494XView further author information
ORCID Icon &
Anne S. De Grootc EpiVax, Inc., Providence, RI, USA;d Center for Vaccines and Immunology, University of Georgia, Athens, GA, USAORCID Iconhttps://orcid.org/0000-0001-5911-1459View further author information
ORCID Icon
Pages 205-212 | Received 12 Oct 2023, Accepted 04 Jan 2024, Published online: 10 Jan 2024

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.